FRM
Fox Run Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,973
| Closed | -$69.2K | – | 835 |
|
|
2024
Q2 | $69.2K | Sell |
14,973
-26,759
| -64% | -$124K | 0.01% | 733 |
|
|
2024
Q1 | $341K | Buy |
+41,732
| New | +$341K | 0.07% | 492 |
|
|
2022
Q2 | – | Sell |
-8,926
| Closed | -$217K | – | 550 |
|
|
2022
Q1 | $217K | Buy |
+8,926
| New | +$217K | 0.12% | 388 |
|